Dr. Deborah Schrag wrote an editorial for JAMA talking about the need for more treatments for Pancreatic Cancer.
Dr. Jennifer Ligibel is leading research to see if weight loss can prevent breast cancer recurrence.
Dr. Rachel Freedman comments on a study showing older black women with human epidermal growth factor receptor 2 (HER2)–positive breast cancer are less likely than their white peers to receive targeted therapy.
Dr. David A. Williams, president of Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, comments on why pediatric cancers should be a priority for research funds.
Dr. Geoffrey Oxnard led a study showing how a simple blood test can help treat patients with certain lung cancers.
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free: